Parkinson's Disease Trial, Recruiting NCT05307055 Sponsor: University of Southern California Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05307055
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have previously had a deep brain stimulation (DBS) device implanted on both sides of the brain in an area called the subthalamic nucleus (STN)
  • You are older than 18 years of age
  • Your medications have stayed the same for at least the past 3 months
  • You have been fully informed about the trial and are able to sign a written consent form
  • You are able to attend all required appointments, tests, and follow-up visits and follow the study procedures

Who may not be able to join:

  • You have a history of epilepsy or seizures
  • You have a history of dementia
  • You have a history of serious substance or drug misuse

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Darrin Lee, MD PhD, University of Southern California, Keck School of Medicine

Phone: 9495220866

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 January 2022
Est. completion
31 August 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluation of motor symptoms; Evaluation of executive functioning; Neuroimaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov